This content is unpublished, click the edit tab and check "Published" on the bottom of the form.
24.
04.15
15:47
Close share menu
Bristol-Myers Squibb receives positive CHMP opinion in the European Union for Opdivo (nivolumab) for the treatment of advanced melanoma in both first-line and previously treated patients